BDX vs UTMD
BDX: BD is a leading global medical technology company providing essential medical devices, diagnostic systems, and laboratory solutions to healthcare providers and researchers worldwide. UTMD: Utah Medical Products develops and manufactures specialized, cost-effective medical devices designed to improve patient safety and outcomes in labor, delivery, and neonatal intensive care.
Side-by-side fundamentals
| Metric | BDX | UTMD | Edge |
|---|---|---|---|
| Price as of 2026-07-31 close | $165.62 | $70.52 | |
| Market cap as of 2026-08-03 | $45.6B | $225M | |
| P/E as of 2026-08-03 | 42.05 | 20.87 | UTMD lower |
| PEG as of 2026-08-03 | -24.04 | n/a | |
| Net margin as of 2026-08-03 | +5.3% | +28.9% | UTMD higher |
| Gross margin as of 2026-08-03 | +47.0% | +57.9% | UTMD higher |
| Operating margin as of 2026-08-03 | +10.2% | +28.8% | UTMD higher |
| ROE as of 2026-08-03 | +4.5% | +9.1% | UTMD higher |
| ROA as of 2026-08-03 | +2.1% | +8.9% | UTMD higher |
| Debt / equity as of 2026-08-03 | 0.72 | 0.00 | UTMD lower |
| Revenue growth (YoY) as of 2026-08-03 | +2.4% | -4.4% | BDX higher |
| Revenue CAGR (3y) SEC XBRL | +5.0% | -9.7% | BDX higher |
| Dividend yield as of 2026-08-03 | +2.5% | +1.8% | BDX higher |
| Dividend streak (yrs) SEC XBRL | 5 | n/a | |
| Beta as of 2026-08-03 | 0.44 | 0.38 | |
| 1-year return as of 2026-07-31 close | +18.2% | +26.8% | UTMD higher |
Fundamentals: market data, as of 2026-08-03. Filings: SEC EDGAR. Prices are delayed daily-close data.
Last updated 2026-07-31.
Informational only — NOT financial advice. All figures are delayed daily-close data from SEC EDGAR & market data, shown with their as-of date; "Edge" cells are a pure numeric comparison, not a recommendation.